Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $11.0 million.

  • iBio's Non-Current Assets fell 1794.43% to $11.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.8 million, marking a year-over-year decrease of 463.72%. This contributed to the annual value of $13.5 million for FY2025, which is 307.76% up from last year.
  • Per iBio's latest filing, its Non-Current Assets stood at $11.0 million for Q4 2025, which was down 1794.43% from $13.4 million recorded in Q3 2025.
  • iBio's Non-Current Assets' 5-year high stood at $59.0 million during Q4 2021, with a 5-year trough of $11.0 million in Q4 2025.
  • Its 5-year average for Non-Current Assets is $25.0 million, with a median of $14.5 million in 2023.
  • In the last 5 years, iBio's Non-Current Assets surged by 7075.66% in 2021 and then tumbled by 7698.98% in 2022.
  • Over the past 5 years, iBio's Non-Current Assets (Quarter) stood at $59.0 million in 2021, then plummeted by 76.99% to $13.6 million in 2022, then increased by 5.59% to $14.3 million in 2023, then fell by 6.47% to $13.4 million in 2024, then decreased by 17.94% to $11.0 million in 2025.
  • Its Non-Current Assets was $11.0 million in Q4 2025, compared to $13.4 million in Q3 2025 and $13.5 million in Q2 2025.